Cited by 843Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsNeurological Disease Mechanisms and Treatments

A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease

Open access
Baik, Sung Hoon, Kang, Seokjo, Lee, Woochan, Choi, Hayoung, Chung, Sunwoo, Kim, Jong-Il, Mook-Jung, Inhee·2019·Cell Metabolism

Abstract

Reactive microglia are a major pathological feature of Alzheimer's disease (AD). However, the exact role of microglia in AD pathogenesis is still unclear. Here, using metabolic profiling, we found that exposure to amyloid-β triggers acute microglial inflammation accompanied by metabolic reprogramming from oxidative phosphorylation to glycolysis. It was dependent on the mTOR-HIF-1α pathway. However, once activated, microglia reached a chronic tolerant phase as a result of broad defects in energy metabolisms and subsequently diminished immune responses, including cytokine secretion and phagocytosis. Using genome-wide RNA sequencing and multiphoton microscopy techniques, we further identified metabolically defective microglia in 5XFAD mice, an AD mouse model. Finally, we showed that metabolic boosting with recombinant interferon-γ treatment reversed the defective glycolytic metabolism and inflammatory functions of microglia, thereby mitigating the AD pathology of 5XFAD mice. Collectively, metabolic reprogramming is crucial for microglial functions in AD, and modulating metabolism might be a new therapeutic strategy for AD.

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2019.06.005

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Acute exposure of primary microglia to Aβ increases inflammatory cytokine secretion and phagocytic performance, while chronic exposure reduces phagocytosis and induces immune tolerance, as well as a metabolic shift from oxidative phosphorylation to glycolysis.

    “Acute exposure of primary microglia to Aβ increased their inflammatory cytokine secretion and phagocytic performance, while chronic exposure reduced phagocytosis and induced immune tolerance, as well as a metabolic shift from oxidative phosphorylation to glycolysis77.”
  • The efficiency of individual phagocytic processes can be dependent on experimental conditions.

    “although it is important to note that the efficiency of individual phagocytic processes can be dependent on experimental conditions65–67.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Baik, S. H., Kang, S., Lee, W., Choi, H., Chung, S., Kim, J.-I., & Mook-Jung, I.
Affiliations
Seoul National University (KR)
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2019-09
Volume
30
Issue
3
Pages
493-507.e6
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2954390789
Cited by
843
References
20
Citations by year
2026: 150 · 2025: 144 · 2024: 171 · 2023: 113 · 2022: 123 · 2021: 82 · 2020: 50 · 2019: 9
FWCI
29.30
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
Funders
National Research Foundation of Korea
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, microglia, metabolic reprogramming, amyloid-beta, microglial inflammation, oxidative phosphorylation, glycolysis, mTOR, HIF-1α, energy metabolism, phagocytosis, cytokine production, interferon-gamma, 5xFAD mice, treatment options
MeSH terms
Alzheimer Disease, Animals, Cell Line, Disease Models, Animal, Female, Gene Expression Regulation, Glycolysis, Inflammation, Interferon-gamma, Male, Mice, Inbred ICR, Mice, Transgenic, Oxidative Phosphorylation, Phagocytosis, Recombinant Proteins, Cytokines, Amyloid beta-Peptides, Microglia, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review